Sara Borghi

Dr. Sara Borghi

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
SBSara Borghi
Sara Borghi
SBStylianos Bournazos
Stylianos Bournazos
NTNatalie K. Thulin
Natalie K. Thulin
CLChao Li
Chao Li
AGAnna Gajewski
Anna Gajewski
TWTaia Wang
Taia Wang
Significance: Transport of IgG antibodies from the maternal to the fetal circulation is a key process for neonatal immunity, as neonates cannot sufficiently generate IgG antibodies to reach protective levels during the first months after birth. In humans and other primates, maternal to fetal transport of IgG antibodies is largely mediated through the placental tissue. FcRn has been previously identified as the major driver of IgG transplacental transport. Here we examine whether other receptors, such as FcγRs, also contribute to the maternal-fetal IgG transfer. By characterizing the Fc domain structure of paired maternal-fetal IgG samples and modeling transplacental IgG transport in genetically engineered mouse strains, we determined that FcRn, but not FcγRs, is the major receptor that mediates transplacental IgG transport.

17 February 2015 in Stem Cells
Verified
Journal Article
Open access
PDF file
FGFederico Galvagni
Federico Galvagni
CLClaudia Lentucci
Claudia Lentucci
FNFrancesco Neri
Francesco Neri
DDDaniela Dettori
Daniela Dettori
CCCaterina De Clemente
Caterina De Clemente
SOSalvatore Oliviero
Salvatore Oliviero
Although much is known about the pluripotency self-renewal circuitry, the molecular events that lead embryonic stem cells (ESCs) exit from pluripotency and begin differentiation are largely unknown. We found that the zinc finger transcription factor Snai1, involved in gastrulation and epithelial-mesenchymal transition, is already expressed in the inner cell mass of the preimplantation blastocysts. In ESCs, Snai1 does not respond to TGFβ or BMP4 signaling but it is induced by retinoic acid treatment, which induces the binding, on the Snai1 promoter, of the retinoid receptors RARγ and RXRα, the dissociation of the Polycomb repressor complex 2 which results in the decrease of H3K27me3, and the increase of histone H3K4me3. Snai1 mediates the repression of pluripotency genes by binding directly to the promoters of Nanog, Nr5a2, Tcl1, c-Kit, and Tcfcp2l1. The transient activation of Snai1 in embryoid bodies induces the expression of the markers of all three germ layers. These results suggest that Snai1 is a key factor that triggers ESCs exit from the pluripotency state and initiate their differentiation processes. Stem Cells 2015;33:742–750

21 November 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
KKKevin S. Kao
Kevin S. Kao
AGAaron Gupta
Aaron Gupta
GZGuanghui Zong
Guanghui Zong
CLChao Li
Chao Li
IKIsabell Kerschbaumer
Isabell Kerschbaumer
JRJeffrey V. Ravetch
Jeffrey V. Ravetch
Protein glycosylation is a crucial mediator of biological functions and is tightly regulated in health and disease. However, interrogating complex protein glycoforms is challenging, as current lectin tools are limited by cross-reactivity while mass spectrometry typically requires biochemical purification and isolation of the target protein. Here, we describe a method to identify and characterize a class of nanobodies that can distinguish glycoforms without reactivity to off-target glycoproteins or glycans. We apply this technology to immunoglobulin G (IgG) Fc glycoforms and define nanobodies that specifically recognize either IgG lacking its core-fucose or IgG bearing terminal sialic acid residues. By adapting these tools to standard biochemical methods, we can clinically stratify dengue virus and SARS-CoV-2 infected individuals based on their IgG glycan profile, selectively disrupt IgG–Fcγ receptor binding both in vitro and in vivo, and interrogate the B cell receptor (BCR) glycan structure on living cells. Ultimately, we provide a strategy for the development of reagents to identify and manipulate IgG Fc glycoforms.

11 March 2026 in Nature Communications
Verified
Journal Article
Open access
VCValeria Calvaresi
Valeria Calvaresi
LILucia Dello Iacono
Lucia Dello Iacono
SBSara Borghi
Sara Borghi
ELEnrico Luzzi
Enrico Luzzi
ABAlessia Biolchi
Alessia Biolchi
NNNathalie Norais
Nathalie Norais
Structural knowledge of antigens in their native state can drive the design of optimized vaccine antigens that mimic the native epitope exposure and conformation. Here, by hydrogen-deuterium exchange mass spectrometry, we assessed the structural features of Neisseria Adhesin A (NadA), a meningococcal trimeric outer membrane protein, included as soluble recombinant antigen in the 4CMenB vaccine. We propose a structural annotation of the recombinant NadA and compare its structural dynamics with NadA in situ, as embedded in meningococcal outer membrane vesicles (OMVs). The observed conformational differences suggest that OMV-embedded NadA could be more susceptible to trimer opening and display a larger antigenic surface than the soluble antigen. Accordingly, mice immunized with OMV-embedded NadA elicited antibodies with superior bactericidal activity compared to the soluble antigen. Collectively, these data support the hypothesis that protein vaccine antigens presented in native-like environments can elicit a more potent immune response than recombinant forms.

18 April 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
SBSara Borghi
Sara Borghi
AAAna Antunes
Ana Antunes
AHAndreas F Haag
Andreas F Haag
MSMarco Spinsanti
Marco Spinsanti
TBTarcisio Brignoli
Tarcisio Brignoli
IDIsabel Delany
Isabel Delany
Neisseria meningitidis colonizes the nasopharynx of humans, and pathogenic strains can disseminate into the bloodstream, causing septicemia and meningitis. NHBA is a surface-exposed lipoprotein expressed by all N. meningitidis strains in different isoforms. Diverse roles have been reported for NHBA in heparin-mediated serum resistance, biofilm formation, and adherence to host tissues. We determined that temperature controls the expression of NHBA in all strains tested, with increased levels at 30–32 °C compared to 37 °C. Higher NHBA expression at lower temperatures was measurable both at mRNA and protein levels, resulting in higher surface exposure. Detailed molecular analysis indicated that multiple molecular mechanisms are responsible for the thermoregulated NHBA expression. The comparison of mRNA steady-state levels and half-lives at 30 °C and 37 °C demonstrated an increased mRNA stability/translatability at lower temperatures. Protein stability was also impacted, resulting in higher NHBA stability at lower temperatures. Ultimately, increased NHBA expression resulted in higher susceptibility to complement-mediated killing. We propose that NHBA regulation in response to temperature downshift might be physiologically relevant during transmission and the initial step(s) of interaction within the host nasopharynx. Together these data describe the importance of NHBA both as a virulence factor and as a vaccine antigen during neisserial colonization and invasion.

17 November 2024 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
NNNathaniel C. Nelson
Nathaniel C. Nelson
KWKendrew K. Wong
Kendrew K. Wong
IMIan J. Mahoney
Ian J. Mahoney
TMTahir Malik
Tahir Malik
DRDarya Rudym
Darya Rudym
JNJake G. Natalini
Jake G. Natalini